Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.005 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2003Polymorphic hydroxylation of perhexiline in vitroSorensen, L.; Sorensen, R.; Miners, J.; Somogyi, A.; Grgurinovich, N.; Birkett, D.
2008Evolution of PharmacogenomicsSomogyi, A.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
2002Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transportersGlaeser, H.; Drescher, S.; Van der Kuip, H.; Behrens, C.; Geick, A.; Burk, O.; Dent, J.; Somogyi, A.; von Richter, O.; Griese, E.; Eichelbaum, M.; Fromm, M.
1996The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Capon, D.; Bochner, F.; Kerry, N.; Mikus, G.; Danz, C.; Somogyi, A.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.
1996Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.Somogyi, A.; Reinhard, H.; Bochner, F.